<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="id">
	<id>https://wiki.unissula.ac.id/index.php?action=history&amp;feed=atom&amp;title=Antibodi_antinukleus</id>
	<title>Antibodi antinukleus - Riwayat revisi</title>
	<link rel="self" type="application/atom+xml" href="https://wiki.unissula.ac.id/index.php?action=history&amp;feed=atom&amp;title=Antibodi_antinukleus"/>
	<link rel="alternate" type="text/html" href="https://wiki.unissula.ac.id/index.php?title=Antibodi_antinukleus&amp;action=history"/>
	<updated>2026-09-15T23:55:37Z</updated>
	<subtitle>Riwayat revisi halaman ini di wiki</subtitle>
	<generator>MediaWiki 1.46.0</generator>
	<entry>
		<id>https://wiki.unissula.ac.id/index.php?title=Antibodi_antinukleus&amp;diff=29265&amp;oldid=prev</id>
		<title>Maintenance script: Presentation V4: sitasi, referensi, Math, Wikimedia Commons, dan atribusi</title>
		<link rel="alternate" type="text/html" href="https://wiki.unissula.ac.id/index.php?title=Antibodi_antinukleus&amp;diff=29265&amp;oldid=prev"/>
		<updated>2026-08-30T04:15:09Z</updated>

		<summary type="html">&lt;p&gt;Presentation V4: sitasi, referensi, Math, Wikimedia Commons, dan atribusi&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw-interface=&quot;&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;id&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Revisi sebelumnya&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revisi per 30 Agustus 2026 04.15&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l1&quot;&gt;Baris 1:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Baris 1:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;[[File:ANA_Immunofluorescence.png|thumb|right|280px|ANA Immunofluorescence]]&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;#039;&amp;#039;&amp;#039;Antibodi anti-nukleus&amp;#039;&amp;#039;&amp;#039; (&amp;#039;&amp;#039;&amp;#039;ANA&amp;#039;&amp;#039;&amp;#039;, &amp;#039;&amp;#039;Anti-nuclear antibodies&amp;#039;&amp;#039;) atau dikenal juga sebagai &amp;#039;&amp;#039;&amp;#039;Faktor anti-nukleus&amp;#039;&amp;#039;&amp;#039; (&amp;#039;&amp;#039;&amp;#039;ANF&amp;#039;&amp;#039;&amp;#039;, &amp;#039;&amp;#039;Anti-nuclear factor&amp;#039;&amp;#039;) adalah [[antibodi]] yang timbul lebih tinggi ketika terjadi [[penyakit autoimun]]. Uji ANA mengukur pola dan jumlah dari autoantibodi yang dapat merusak jaringan tubuh bila jaringan tersebut dianggap sebagai benda asing. Setiap individu memiliki autoantibodi dalam jumlah yang sedikit, tetapi sekitar 5% dari populasi terdapat autoantibodi yang meningkat. Setengah dari 5% tersebut menderita penyakit autoimun.&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;#039;&amp;#039;&amp;#039;Antibodi anti-nukleus&amp;#039;&amp;#039;&amp;#039; (&amp;#039;&amp;#039;&amp;#039;ANA&amp;#039;&amp;#039;&amp;#039;, &amp;#039;&amp;#039;Anti-nuclear antibodies&amp;#039;&amp;#039;) atau dikenal juga sebagai &amp;#039;&amp;#039;&amp;#039;Faktor anti-nukleus&amp;#039;&amp;#039;&amp;#039; (&amp;#039;&amp;#039;&amp;#039;ANF&amp;#039;&amp;#039;&amp;#039;, &amp;#039;&amp;#039;Anti-nuclear factor&amp;#039;&amp;#039;) adalah [[antibodi]] yang timbul lebih tinggi ketika terjadi [[penyakit autoimun]]. Uji ANA mengukur pola dan jumlah dari autoantibodi yang dapat merusak jaringan tubuh bila jaringan tersebut dianggap sebagai benda asing. Setiap individu memiliki autoantibodi dalam jumlah yang sedikit, tetapi sekitar 5% dari populasi terdapat autoantibodi yang meningkat. Setengah dari 5% tersebut menderita penyakit autoimun.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l7&quot;&gt;Baris 7:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Baris 9:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;Antibodi anti-nukleus adalah antibodi yang tak biasa, dapat dideteksi di darah, memiliki kemampuan untuk mengikat struktur tertentu pada nukleus sel. [[Nukleus]] menganduk [[Asam deoksiribonukleat|DNA]], materi genetika. ANA ditemukan pada pasien dengan sistem imun yang telah tertekan faktor predisposisi dan akhirnya terkena [[radang]] serta merusakan jaringan tubuh sendiri.&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;Antibodi anti-nukleus adalah antibodi yang tak biasa, dapat dideteksi di darah, memiliki kemampuan untuk mengikat struktur tertentu pada nukleus sel. [[Nukleus]] menganduk [[Asam deoksiribonukleat|DNA]], materi genetika. ANA ditemukan pada pasien dengan sistem imun yang telah tertekan faktor predisposisi dan akhirnya terkena [[radang]] serta merusakan jaringan tubuh sendiri.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;Dengan ditemukannya titer ANA yang tinggi (1:160 misalnya), berbagai subtipe ANA dapat dibedakan. Berikut adalah subtipe pada sel &#039;&#039;HEp-2&#039;&#039;, misalnya:&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;Dengan ditemukannya titer ANA yang tinggi (1:160 misalnya), berbagai subtipe ANA dapat dibedakan.&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;&amp;lt;ref&amp;gt;Kavanaugh A, Tomar R, Reveille J, Solomon DH, Homburger HA. &#039;&#039;Guidelines for clinical use of the antinuclear antibody test and tests for specific autoantibodies to nuclear antigens. American College of Pathologists.&#039;&#039; Arch Pathol Lab Med 2000;124:71-81. PMID 10629135.&amp;lt;/ref&amp;gt; &lt;/ins&gt;Berikut adalah subtipe pada sel &#039;&#039;HEp-2&#039;&#039;, misalnya:&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Anti-ENA (&amp;#039;&amp;#039;Extractable nuclear antigen&amp;#039;&amp;#039;)&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Anti-ENA (&amp;#039;&amp;#039;Extractable nuclear antigen&amp;#039;&amp;#039;)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* [[Antibodi Anti-glycoprotein-210|Anti-gp-210]] ([[glycoprotein-210 pori nuklear|gp-210 pori nuklear]])&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* [[Antibodi Anti-glycoprotein-210|Anti-gp-210]] ([[glycoprotein-210 pori nuklear|gp-210 pori nuklear]])&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l19&quot;&gt;Baris 19:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Baris 21:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* [[Antobodi Anti-centromere|Anti-centromere]]&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* [[Antobodi Anti-centromere|Anti-centromere]]&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Anti-Jo&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Anti-Jo&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-added&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;== Referensi ==&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-added&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-added&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;== Pranala luar ==&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;== Pranala luar ==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*  [http://www.antibodypatterns.com Site with unique immunofluorescence images and slides -organ and non-organ specific]&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*  [http://www.antibodypatterns.com Site with unique immunofluorescence images and slides -organ and non-organ specific]&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;== Referensi ==&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;&amp;lt;references /&amp;gt;&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;== Sumber dan atribusi ==&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;== &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;Sumber &lt;/del&gt;dan &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;atribusi ==&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;Konten artikel ini diadaptasi dari [https://id.wikipedia.org/w/index.php?title&lt;/ins&gt;=&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;Antibodi+antinukleus&amp;amp;oldid&lt;/ins&gt;=&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;29590558 Wikipedia bahasa Indonesia], revisi 29590558 (2026-08-17T00:41:50Z), yang tersedia berdasarkan lisensi Creative Commons Atribusi-BerbagiSerupa (CC BY-SA). Gambar pada artikel ini bersumber dari Wikimedia Commons &lt;/ins&gt;dan &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;mengikuti ketentuan lisensi masing-masing berkas. Mohon gunakan konten dan media secara bijak serta sesuai dengan ketentuan lisensi yang berlaku.&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;Konten artikel ini diadaptasi dari [https://id.wikipedia.org/w/index.php?title=Antibodi+antinukleus&amp;amp;oldid=29590558 Wikipedia bahasa Indonesia], revisi 29590558 (2026&lt;/del&gt;-&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;08&lt;/del&gt;-&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;17T00:41:50Z), yang tersedia berdasarkan lisensi Creative Commons Atribusi&lt;/del&gt;-&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;BerbagiSerupa (CC BY&lt;/del&gt;-&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;SA). Mohon gunakan konten ini secara bijak serta sesuai dengan ketentuan lisensi yang berlaku.&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;&amp;lt;!&lt;/ins&gt;-- &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;WIKI_UNISSULA_PRESENTATION_V4 &lt;/ins&gt;--&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;&amp;gt;&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Maintenance script</name></author>
	</entry>
	<entry>
		<id>https://wiki.unissula.ac.id/index.php?title=Antibodi_antinukleus&amp;diff=28866&amp;oldid=prev</id>
		<title>Maintenance script: Impor teks terkontrol dari Wikipedia bahasa Indonesia; revisi 29590558; atribusi sumber disertakan.</title>
		<link rel="alternate" type="text/html" href="https://wiki.unissula.ac.id/index.php?title=Antibodi_antinukleus&amp;diff=28866&amp;oldid=prev"/>
		<updated>2026-08-30T03:52:25Z</updated>

		<summary type="html">&lt;p&gt;Impor teks terkontrol dari Wikipedia bahasa Indonesia; revisi 29590558; atribusi sumber disertakan.&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Halaman baru&lt;/b&gt;&lt;/p&gt;&lt;div&gt;&amp;#039;&amp;#039;&amp;#039;Antibodi anti-nukleus&amp;#039;&amp;#039;&amp;#039; (&amp;#039;&amp;#039;&amp;#039;ANA&amp;#039;&amp;#039;&amp;#039;, &amp;#039;&amp;#039;Anti-nuclear antibodies&amp;#039;&amp;#039;) atau dikenal juga sebagai &amp;#039;&amp;#039;&amp;#039;Faktor anti-nukleus&amp;#039;&amp;#039;&amp;#039; (&amp;#039;&amp;#039;&amp;#039;ANF&amp;#039;&amp;#039;&amp;#039;, &amp;#039;&amp;#039;Anti-nuclear factor&amp;#039;&amp;#039;) adalah [[antibodi]] yang timbul lebih tinggi ketika terjadi [[penyakit autoimun]]. Uji ANA mengukur pola dan jumlah dari autoantibodi yang dapat merusak jaringan tubuh bila jaringan tersebut dianggap sebagai benda asing. Setiap individu memiliki autoantibodi dalam jumlah yang sedikit, tetapi sekitar 5% dari populasi terdapat autoantibodi yang meningkat. Setengah dari 5% tersebut menderita penyakit autoimun.&lt;br /&gt;
&lt;br /&gt;
== Autoimunitas ==&lt;br /&gt;
Titer normal dari ANA adalah 1:40. Titer yang lebih tinggi menandakan sebuah penyakit autoimun. Adanya ANA mengindikasikan [[lupus erythematosus]] (terdapat pada 80-90% dari kasus). Hal serupa juga timbul pada 60% kasus [[sindrom Sjögren]], [[arthritis rheumatoid]], [[hepatitis autoimun]], [[skleroderma]], [[polimiositis]], [[dermatositis]], dan berbagai kondisi non-rheumatologis yang berhubungan dengan kerusakan jaringan. ANA juga dirujuk langsung ke [[kompleks pori nukleus]] pada [[sirosis biliaris primer]]. Kondisi lainnya dengan titer ANA tinggi seperti pada [[penyakit Addison]], purpura trombositopenik primer, [[penyakit Hashimoto]], [[anemia hemolitik]] autoimun, [[Diabetes melitus tipe 2|diabetes melitus tipe I]], kelainan jaringan ikat campuran.&lt;br /&gt;
&lt;br /&gt;
== Antibodi anti-nukleus ==&lt;br /&gt;
Antibodi anti-nukleus adalah antibodi yang tak biasa, dapat dideteksi di darah, memiliki kemampuan untuk mengikat struktur tertentu pada nukleus sel. [[Nukleus]] menganduk [[Asam deoksiribonukleat|DNA]], materi genetika. ANA ditemukan pada pasien dengan sistem imun yang telah tertekan faktor predisposisi dan akhirnya terkena [[radang]] serta merusakan jaringan tubuh sendiri.&lt;br /&gt;
&lt;br /&gt;
Dengan ditemukannya titer ANA yang tinggi (1:160 misalnya), berbagai subtipe ANA dapat dibedakan. Berikut adalah subtipe pada sel &amp;#039;&amp;#039;HEp-2&amp;#039;&amp;#039;, misalnya:&lt;br /&gt;
* Anti-ENA (&amp;#039;&amp;#039;Extractable nuclear antigen&amp;#039;&amp;#039;)&lt;br /&gt;
* [[Antibodi Anti-glycoprotein-210|Anti-gp-210]] ([[glycoprotein-210 pori nuklear|gp-210 pori nuklear]])&lt;br /&gt;
* [[Antobodi Anti-p62|Anti-p62]] ([[Nucleoporin 62]])&lt;br /&gt;
* Anti-dsDNA (DNA rantai ganda)&lt;br /&gt;
* Anti-Ro (SS-A)&lt;br /&gt;
* Anti-La (SS-B)&lt;br /&gt;
* [[LSm|Anti-Sm (Antigen &amp;#039;&amp;#039;Smith&amp;#039;&amp;#039;)]]&lt;br /&gt;
* Anti-nRNP (ribonukleoprotein nukleus)&lt;br /&gt;
* [[Anti Scl-70]] ([[topoisomerase I]])&lt;br /&gt;
* [[Antobodi Anti-centromere|Anti-centromere]]&lt;br /&gt;
* Anti-Jo&lt;br /&gt;
&lt;br /&gt;
== Referensi ==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Pranala luar ==&lt;br /&gt;
*  [http://www.antibodypatterns.com Site with unique immunofluorescence images and slides -organ and non-organ specific]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Sumber dan atribusi ==&lt;br /&gt;
&lt;br /&gt;
Konten artikel ini diadaptasi dari [https://id.wikipedia.org/w/index.php?title=Antibodi+antinukleus&amp;amp;oldid=29590558 Wikipedia bahasa Indonesia], revisi 29590558 (2026-08-17T00:41:50Z), yang tersedia berdasarkan lisensi Creative Commons Atribusi-BerbagiSerupa (CC BY-SA). Mohon gunakan konten ini secara bijak serta sesuai dengan ketentuan lisensi yang berlaku.&lt;/div&gt;</summary>
		<author><name>Maintenance script</name></author>
	</entry>
</feed>